Speaker: Tomas Kalincik, Head, Neuroimmunology Centre, Royal Melbourne Hospital
What key insights will you be sharing in your session?
Tomas Kalincik: Hi. My name is Tomas Kalincik. At the upcoming MSMilan2023 conference, I will be discussing principles of one of the two general approaches to treatment of multiple sclerosis, and that is the strategy of treatment escalation. I will be providing an overview of some of the evidence around treatment initiation, the rules for sequencing and the limitations of this approach.
Why is MSMilan2023 such an important event for MS experts and neurologists?
Tomas Kalincik: As every year, the annual ECTRIMS meeting will be the highlight of the research year in neuroimmunology. We will have two societies come together, the American and the European Society for Treatment and Research in Multiple Sclerosis to provide you with the best and the highlights of research and the news in clinical practice in neuroimmunology.
